Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Research from Hallym University provide new insights into breast cancer
July 2nd, 2009
According to recent research from South Korea, "Most anticancer agents activate nuclear factor kappa B (NF-kappa B), which can mediate cell survival, proliferation, and metastasis. Curcumin has been shown to inhibit the growth of various cancer cells, without toxicity to normal cells." "The antitumor effects of curcumin could be due in part to the inactivation of NF-kappa B. We hypothesize that blocking NF-kappa B activity may augment paclitaxel cancer chemotherapy. In this study, we investigated whether the inactivation of NF-kappa B by curcumin would enhance the efficacy of paclitaxel for inhibiting breast cancer growth in vitro and in vivo. We confirmed that curcumin...
Source: Women's Health Weekly (2009-07-02)
|
